期刊文献+

帕瑞昔布钠在无痛人工流产术中的应用

The Application of Parecoxib Sodium in Painless Artificial Abortion
下载PDF
导出
摘要 目的探讨帕瑞昔布钠复合丙泊酚麻醉用于无痛人工流产术的镇痛效果和安全性。方法 120例美国医师协会(ASA)分级Ⅰ或Ⅱ级门诊无痛人工流产术患者,随机分为A、B两组,每组60例。B组术前15min帕瑞昔布钠40mg静脉注射,两组均给予丙泊酚2mg/kg静脉注射,术中根据患者体动反应追加丙泊酚至体动反应消失。观察术前、术中、术后的MAP、HR与丙泊酚用药总量、术后苏醒时间、术后30min宫缩疼痛VAS评分及恶心呕吐、头晕、嗜睡、皮肤瘙痒、呼吸抑制、异常出血等不良反应。结果与A组比较,B组丙泊酚的用药总量明显减少(P<0.05),呼吸抑制的发生率减少(P<0.05);术后30min宫缩疼痛VAS评分B组优于A组(P<0.01),而不良反应没有增加。结论帕瑞昔布钠复合丙泊酚用于无痛人工流产术,可减少丙泊酚的用量和呼吸抑制的发生,增强镇痛效果而不增加不良反应。 Objective To investigate the efficacy and safety of artificial abortion combined anesthesia using parecoxibna and ropofol. Methods The 120 out-patients ( ASA I - II )required induced abortion of indolence randomly divided into group A and group B, with 60 cases in each group. Group B was injected parecoxibna 40 mg 15 minutes before operation, ropofol was given in accordance with body action until it disappeared in the operation. MAP, HR, total dosage of propofol, awake time after operation, VAS scores of womb reducing pain 30 minutes after operation, adverse reactions such as nausea, vomiting, dizziness, lethargy, pruritus, respiratory depression and abnormal bleeding were observed. Results Compared with group A, the total drug of propofol of group B significantly reduced (P 〈 0.05 ) ; The incidence of respiratory depression of group B reduced (P 〈 0.05 ) ; Contractions pain VAS score of Postoperative 30 min was better in group B than in group A (P 〈 0.01 ), but no adverse reactions increased. Conclusion Parecoxib sodium and propofol for painless abortion can reduce the amount of propofol and the occurrence of respiratory depression, and enhance the analgesic effect without increasing side effects.
出处 《中国现代医生》 2011年第29期87-88,共2页 China Modern Doctor
关键词 帕瑞昔布钠 丙泊酚 人工流产术 镇痛 Parecoxib sodium Propofol Induced abortion Analgesic
  • 相关文献

参考文献7

  • 1倪家骧等主编..临床疼痛治疗技术[M].北京:科学技术文献出版社,2003:876.
  • 2Solca M. Acute pain management: unmet needs and new advances inpain management[J]. Eur J Anaesthesiol Suppl, 2002,25 ( 1 ) : 3-10. 被引量:1
  • 3Dahl JB, Moiniche S. Preemptive analgesia[J]. Br Med Bull, 2004,71 ( 13 ): 13-27. 被引量:1
  • 4Tang J, Li S, White PF, et al. Effect of parecoxib,a novel intravenous cyclooxygenase type-2 inhibitor,on the postoperative opioid requirement and quality of pain control[J]. Anesthesiology,2002,96 ( 6 ) : 1305-1309. 被引量:1
  • 5Malan TP Jr, Marsh G, Hakki SI, et al. Parecoxib sodium,a parenteral cyclooxyenase 2 selective inhibitor,improves morphine analgesia and is opiodsparing following total hip arthroplasty[J]. Anesthesiology, 2003,98 ( 4 ) : 950- 956. 被引量:1
  • 6Kranke P, Morin AM, Roewer N, et al. Patients' global evaluation of analgesia and safety of injected parecoxib for postoperative pain:a quantitative systematic review[J]. Anesth Analg, 2004,99 ( 3 ) : 797-806. 被引量:1
  • 7吴新民,岳云,张利萍,王俊科,艾登滨,于布为,薛张纲,黄文起.术后镇痛中帕瑞昔布钠对吗啡用量的节俭作用和安全性—前瞻性、多中心、随机、双盲、安慰剂对照、平行分组研究[J].中华麻醉学杂志,2007,27(1):7-10. 被引量:367

二级参考文献11

  • 1McArdle P. Intravenous analgesia. Crit Care Clin, 1999,15:89-104. 被引量:1
  • 2Bowdle TA. Adverse effects of opioid agonists and agonist-antagonists in anesthesia. Drug Saf, 1998,19:173-189. 被引量:1
  • 3Kehlet H, Dahl JB. The value of "multimodal" or "balanced analgesia"in postoperative pain treatment. Anesth Analg, 1993,77:1048-1056. 被引量:1
  • 4Power I, Barrett S. Analgesic agents for the postoperative period: nonopioids. Surg Clin North Am, 1999,79:275-295. 被引量:1
  • 5Tong D, Chung F. Postoperative pain control in ambulatory surgery. Surg Clin North Am, 1999,79:401-430. 被引量:1
  • 6Lipsky LP, Abramson SB, Crefford L, et al. The classification of cyclooxygenase inhibitors. J Rheumatol, 1998,25:2298-2303. 被引量:1
  • 7Penning TD, Talley JJ, Berteushaw SR, et al. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenuse-2 inhihitors:identification of 4- [ 5- ( 4-methylphenyl ) -3- ( trifluoremethyl )- 1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib). J Med Chem, 1997,40:1347-1365. 被引量:1
  • 8Tang J, Li S, White PF, et al. Effect of parecoxib, a novel intravenous cyclooxygenuse type-2 inhibitor, on the postoperative opioid requirement and quality of pain control. Anesthesiology, 2002,96: 1305-1309. 被引量:1
  • 9Malan TP Jr,Marsh G, Hakki SI, et al. Parecoxib sodium, a parenteral cyclooxygenuse 2 selective inhibitor, improves morphine analgesia and is opioid-sparing following total hip arthroplasty. Anesthesiology, 2003,98 :950-956. 被引量:1
  • 10Kranke P, Morin AM, Roewer N, et al. Patients' global evaluation of analgesia and safety of injected parecoxib for postoperative pain: a quantitative systematic review. Anesth Analg, 2004,99:797-806. 被引量:1

共引文献366

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部